The Journal of Immunology, Vol 143, Issue 3 913-922, Copyright © 1989 by American Association of Immunologists

ARTICLES

Involvement of class II MHC molecules in the LPS-induction of IL-1/TNF secretions by human monocytes. Quantitative differences at the polymorphic level

P Santamaria, RC Gehrz, MK Bryan and JJ Barbosa
Department of Medicine, University of Minnesota, Minneapolis 55455.

Anti-class II ag mAb (DR and DQ) inhibited, in a dose-dependent manner, LPS-induced IL-1 and TNF secretions from human monocytes (34 to 95% inhibition). The potentiating effect of IFN-gamma on LPS-induced TNF secretion (15.3 +/- 0.7 to 44 +/- 0.6 ng/ml) was also blocked by anti- class II ag mAb (44 +/- 0.6 to 0.3 +/- 0.03 ng/ml). We also report a relationship between interindividual differences in monocyte IL-1 and TNF secretions and the HLA-D-encoded genetic polymorphism. Heterozygotes were, in general, higher secretors of those cytokines than homozygotes. Analysis of these secretions in heterozygotes demonstrated a differential effect of certain haplotype combinations (i.e., DR2-DR4 vs DR2-DR3) that could be arbitrarily characterized as being "low" or "high" secretors (6,230 +/- 2,950 vs 13,029 +/- 6,541 cpm for IL-1, and 12 +/- 10 vs 25 +/- 15 ng/ml for TNF, p = 0.006 and 0.048). DR-associated Dw subtypes appeared to account for differences within certain haplotype combinations (Dw18 vs Dw19 in DRw13/DR4) (11,227 +/- 3,648 vs 17,166 +/- 3,176 cpm for IL-1, and 13 +/- 9 vs 25 +/- 10 ng/ml for TNF, p = 0.02 and 0.047). Interindividual differences were better explained by differences in LPS sensitivity than by differences in the kinetics of secretion and related not to the secretory process itself but to the rate of cytokine synthesis. Finally, there were no relationships between high secretor genotypes and IDD high risk genotypes. Thus, we conclude that, a) LPS-induced IL- 1 and TNF secretions are, at least in part, regulated by class II MHC molecules, b) that HLA-D region-encoded genetic polymorphism accounts for interindividual differences in these secretions, and c) that the HLA-associated risk to develop IDD is not explained by these cytokine secretory differences as previously proposed.

This article has been cited by other articles:

				J. Rodo, L. A. Goncalves, J. Demengeot, A. Coutinho, and C. Penha-Goncalves MHC Class II Molecules Control Murine B Cell Responsiveness to Lipopolysaccharide Stimulation J. Immunol., October 1, 2006; 177(7): 4620 - 4626. [Abstract] [Full Text] [PDF]

				D. A. Schwartz The Genetics of Innate Immunity Chest, March 1, 2002; 121(2007): 62S - 68S. [Abstract] [Full Text] [PDF]

				D. A. Schwartz The role of TLR4 in endotoxin responsiveness in humans Innate Immunity, October 1, 2001; 7(5): 389 - 393. [Abstract] [PDF]

				G. Liuzzo, D. J. Angiolillo, A. Buffon, V. Rizzello, C. Colizzi, F. Ginnetti, L. M. Biasucci, and A. Maseri Enhanced Response of Blood Monocytes to In Vitro Lipopolysaccharide-Challenge in Patients With Recurrent Unstable Angina Circulation, May 8, 2001; 103(18): 2236 - 2241. [Abstract] [Full Text] [PDF]

				G. Liuzzo, L. M. Biasucci, J. R. Gallimore, G. Caligiuri, A. Buffon, A. G. Rebuzzi, M. B. Pepys, and A. Maseri Enhanced inflammatory response in patients with preinfarction unstable angina J. Am. Coll. Cardiol., November 15, 1999; 34(6): 1696 - 1703. [Abstract] [Full Text] [PDF]

				G. Liuzzo, A. Buffon, L. M. Biasucci, J. R. Gallimore, G. Caligiuri, A. Vitelli, S. Altamura, G. Ciliberto, A. G. Rebuzzi, F. Crea, et al. Enhanced Inflammatory Response to Coronary Angioplasty in Patients With Severe Unstable Angina Circulation, December 1, 1998; 98(22): 2370 - 2376. [Abstract] [Full Text] [PDF]

				M. Roger Influence of host genes on HIV-1 disease progression FASEB J, June 1, 1998; 12(9): 625 - 632. [Abstract] [Full Text]

				D. Turbay, J. Lieberman, C. A. Alper, J. C. Delgado, D. Corzo, J. J. Yunis, and E. J. Yunis Tumor Necrosis Factor Constellation Polymorphism and Clozapine-Induced Agranulocytosis in Two Different Ethnic Groups Blood, June 1, 1997; 89(11): 4167 - 4174. [Abstract] [Full Text] [PDF]

				A. Pietersma, M. Kofflard, L. E. A. d. Wit, T. Stijnen, J. F. Koster, P. W. Serruys, and W. Sluiter Late Lumen Loss After Coronary Angioplasty Is Associated With the Activation Status of Circulating Phagocytes Before Treatment Circulation, March 1, 1995; 91(5): 1320 - 1325. [Abstract] [Full Text]